News

August 22, 2017August 22, 2017

Fluidigm, Baylor Genetics Developing New Gene Analysis Tool for Diagnosing Cystic Fibrosis

Fluidigm and Baylor Genetics have teamed up to develop a next-generation gene sequencing method that can quickly identify less common mutations of the gene associated with cystic fibrosis. Up to ... Read more

August 21, 2017August 21, 2017

Dual Contrast Agents May Allow for More Precise and Color-coded MRI Scans

cystic fibrosis, News

Magnetic resonance imaging (MRI) scans, already important to both doctors treating patients and researchers conducting trials, might soon distinguish diseased and healthy tissue in differing colors, improving efforts to map and ... Read more

August 18, 2017August 18, 2017

Interactions Between CFTR Protein and Insulin May Contribute to CF, Review Suggests

cystic fibrosis, News

Scientists have long known that defects in the CFTR protein cause cystic fibrosis. Now they’ve discovered that the defective protein leads to faulty insulin signaling, which, in turn, can cause ... Read more

August 17, 2017August 17, 2017

Corbus Plans to Start Phase 2b Trial of Its Cystic Fibrosis Therapy Anabasum by Year’s End

cystic fibrosis, News

Corbus Pharmaceuticals plans to start a Phase 2b clinical trial of anabasum as a cystic fibrosis treatment by the end of 2017. The decision follows positive results of a Phase 2 study, the company ... Read more

August 16, 2017August 16, 2017

European Experts OK Design of Trial to Assess Sollpura for CF-related Digestive Disorder

cystic fibrosis, News

An influential group of European cystic fibrosis experts has signed off on the design of a Phase 3 clinical trial of Sollpura (lipromatase) as a treatment for a CF-related digestive ... Read more

August 15, 2017

Kate Farms Launches Core Essentials Peptide Tube Feeding Formula for CF, Other Conditions

News

Kate Farms, which specializes in plant-based, ready-to-use oral and tube feeding formulas, has rolled out its Core Essentials Peptide 1.5 product. The high-caloric, peptide-based formula contains no dairy, soy, gluten, ... Read more

August 14, 2017August 14, 2017

CF Patients in Europe Wanted for Phase 2 Trial of Investigational Therapy RPL554

cystic fibrosis, News

Verona Pharma recently announced the company’s accomplishments in the last six months, including an update to the company’s clinical trial in cystic fibrosis (CF) and positive interim results for its investigational ... Read more

August 11, 2017August 11, 2017

Contamination Concerns Lead to FDA Warning Against Use of PharmaTech Liquid Products

News

The U.S. Food and Drug Administration (FDA) is advising patients and healthcare professionals to not use any liquid products made by PharmaTech, LLC due to possible contamination with Burkholderia cepacia bacteria, ... Read more

August 10, 2017August 11, 2017

Sale of Cystic Fibrosis Therapy CTP-656 to Vertex Will Accelerate Its Development, Concert CEO Predicts

News

Concert Pharmaceuticals’ sale of its cystic fibrosis therapy CTP-656 to the larger Vertex Pharmaceuticals will lead to cystic fibrosis patients obtaining faster access to the therapy, Concert CEO Roger Tung predicted. He also said ... Read more

August 9, 2017August 9, 2017

AIT Administers First Doses of Nitric Oxide in a Trial Testing Its Ability to Kill Drug-resistant Bacteria

News

AIT Therapeutics has administered its first doses of nitric oxide in a Phase 2 clinical trial of the compound’s ability to kill the drug-resistant bacteria often found in cystic fibrosis ... Read more